From ISO 13485 to FDA 510(k): How Many Hurdles Does a Needle Need to Clear?

Although the Veress needle is structurally simple, as an invasive medical device, its marketing and clinical application are strictly regulated by regulatory agencies in various countries around the world. The specification parameters you mentioned (length, diameter, shape) are just the tip of the iceberg. What truly determines whether a product can enter the operating room is whether it complies with a series of quality systems and safety standards.

International Standard Framework

ISO 13485:2016: Requirements for Quality Management Systems in Medical Devices. The manufacturer of Veress needles must establish a complete quality system covering the entire process from design and development, procurement, production, inspection, storage, and after-sales service. Key elements include: risk management (ISO 14971), design change control, supplier audits, handling of non-conforming products, corrective and preventive actions (CAPA), etc.

ISO 10993 series: Biocompatibility Evaluation. As Veress needles are devices that come into short-term contact with tissues (<24 hours), they need to undergo tests for cytotoxicity, sensitization, irritation, acute systemic toxicity, hemolysis, and pyrogenicity. Material changes (such as switching to a different brand of stainless steel) or process changes (such as altering the electro-polishing parameters) may trigger a re-evaluation.

ISO 11607: Sterile Barrier Systems. The packaging of disposable Veress needles must undergo verification of sealing strength, microbial barrier performance, and aging stability. Common packaging materials are Tyvek/PE composite film, which requires residual content testing (EO residual ≤ 10 μg/g) after ethylene oxide sterilization.

Market Access by the US FDA

In the United States, the Veress needle is typically classified as a Class II medical device (product code: GCJ) and is subject to the 510(k) pre-market notification process. The applicant must demonstrate that the new product is substantially equivalent to an already legally marketed equivalent device (Predicate Device) in terms of intended use, technical characteristics, materials, performance, etc. The submitted materials include:

Product description and drawings (including all component size tolerances)

Material composition and source proof

Sterilization verification report

Biocompatibility test report

Performance test data (penetration force, spring force, airtightness, fatigue life, etc.)

Labels and user manual

Clinical assessment (if applicable)

The FDA review period is usually 90 to 180 days. If the product involves new materials, new designs, or new indications, it may be required to provide additional clinical data or be upgraded to a PMA (Pre-Marketing Approval).

EU CE Certification

According to EU MDR 2017/745, the Veress needle falls under Class IIa or IIb devices (depending on whether it is reusable and the risk level). The manufacturer must undergo an audit by the notified body and obtain the CE mark. Key requirements include:

Preparation of technical documents (covering design, manufacturing, performance, clinical evaluation, and risk management)

Clinical evaluation report (CER), based on literature search and/or clinical trial data

Post-market surveillance plan (PMS) and regular safety update report (PSUR)

Assignment of Unique Device Identification (UDI) and database registration

China NMPA Registration

In China, Veress needles, as active or passive surgical instruments, need to be registered in accordance with the "Regulations on the Registration of Medical Devices." They are classified as Class II or Class III (if they contain drug coatings or special functions). The registration process includes:

Product technical requirements formulation (refer to the YY/T standards, such as YY 0876-2013 "Laparoscopic Needle Insertion Devices")

Type inspection (completed by provincial or national medical device inspection institutions)

Clinical trial exemption or conduct (for Veress needles with mature technologies, exemption is usually possible)

Quality management system assessment (compliant with the "Good Manufacturing Practice for Medical Devices")

Registration review and approval

Key Performance Indicators and Testing Methods

Regardless of the country, the factory inspection of the Veress needle must cover the following items:

Test Items Standard Requirements Test Methods Appearance and surface quality No burrs, scratches, rust spots, or depressions Visual inspection (10x magnifying glass) Dimensions (outer diameter, inner diameter, length) Tolerance ±0.1 mm Micrometer, image measuring instrument Inclined plane angle Nominal value ±2° Optical projector Spring force (retraction force) 2–5 N (according to design value) Spring tension testing machine Air tightness Leakage ≤0.5 mL under 20 kPa pressure for 30 seconds Air tightness tester Puncture force ≤10 N (simulating human skin + silicone pad) Universal material testing machine Corrosion resistance Salt spray test 24 hours without red rust GB/T 10125 Sterilization adaptability Performance remains unchanged before and after sterilization Comparative test

Reusability vs. One-time Use: The Difference in Quality Management

Reusable type: Additional verification of the repeatability of the cleaning and sterilization procedures is required. Generally, the product needs to be able to withstand at least 50 or 100 reprocessing cycles and undergo functional tests after each cycle. Manufacturers must provide detailed reprocessing instructions (including manual cleaning, ultrasonic cleaning, high-pressure sterilization parameters, etc.).

Disposable type: The focus is on the aseptic assurance level (SAL ≤ 10⁻⁶) and shelf life stability. Accelerated aging tests (typically at 55°C for 6 months, equivalent to 2-3 years) and transportation simulation tests need to be conducted.

Summary

From the drawing board to the operating table, a Veress needle must pass through three hurdles: regulations, quality, and performance. For the purchaser, choosing a brand product that has obtained authoritative certifications (such as CE, FDA, and NMPA) is not only a compliance requirement but also a commitment to patient safety.